<Inspiring Ideas Webinar Series> The Future of Additive Manufacturing – Grand Challenges

Inspiring Ideas Webinar Series

The monthly thematic seminars aim to cover the different aspects of Additive Manufacturing (AM), drawing insights from global academic and industry thought-leaders to generate discussion and action on the advancement of AM technology and its integration into the emerging suite of Industry 4.0 digital technologies.


The Future of Manufacturing – Grand Challenges

What does it take for AM to move beyond? This webinar will continue to explore the grand challenges of AM as a sunrise industry and its potential for growth. There will be two talks followed by a panel discussion. The panel discussion will be moderated by Prof Paulo Bartolo, SC3DP Executive Director.


Speakers

Professor Håvard J. Haugen

Prof Håvard J. Haugen is currently professor and leader of the Biomaterials group at The Institute of Clinical Dentistry, Faculty of Dentistry, University of Oslo. He received a Master in chemical engineering at the Imperial College of Science, Technology and Medicine in London, UK in 2001 and doctoral engineering in biomaterials from the Technische Universität München in 2004. Previously Haugen has been working at the Central Institute for Medical Engineering in Munich (2001-2004), at Helmholtz Institute for Biomedical Engineering in Aachen (1999) and the Tissue Engineering Centre at Imperial College, London (2000-2001).

Haugen has been granted more than 10 million Euros in various research grants in the past five years from the European Research Council and the Research Council of Norway. Haugen has about 160 publications and H-index of 37. He has been awarded the British Petroleum Prize in 2000, the University of Oslo Innovation Prize in 2008 and the German innovation award for 2009 (Innovationspreis 2009 der Deutschen BioRegionen) and Spark Innovation Award (University of Oslo) in 2021. From 2012-2016 Haugen was the President of the Scandinavian Society for Biomaterials (www.scsb.eu).

The research group of Prof. Haugen bridges the gap between basic materials research and clinical treatment. UiO hub is highly interdisciplinary, with extensive experience in dental biomaterials development, modification of biomaterials, soft tissue and hard tissue regeneration and integration of biomaterials into soft and related hard tissues, using methods from biomaterials, odontology, and biochemistry. His group currently has and operates advanced micro- and nanoscale X-ray imaging systems. In addition, Haugen is also involved with commercialising medical devices and is working part-time at Corticalis AS (www.corticalis.com), where he and his colleagues have patented and launched several products commercially in the dental field.

Professor Matteo Santin

Prof Matteo Santin is Professor of Tissue Regeneration at the School of Applied Sciences, University of Brighton, UK, and the Director of the Brighton Centre for Regenerative Medicine and Devices. His career in biomedical research and teaching started in 1989 and it has been marked by significant achievements that were internationally recognised in 2005 by the European Society for Biomaterials who conferred him the Jean Leary Award, elected him as a member of the board (2009-2013) and as the President of the Society (2013-2017). He is the founder and director of 2 start-up companies with a mission in biomaterials, Brighton Wound Care Ltd and Tissue Click Ltd.

His scientific interests include natural biomaterials, synthetic biomimetic nano-structured biomaterials able to control tissue regeneration by differentiated and stem cell phenotypic tuning. He has developed in vitro clinically-reflective models for the testing of biomaterials and tissue engineering constructs and more recently organotypic co-culture (organ-on-chip) models . He has published over 90 papers, filed 10 patents applications and unveiled for the first time the biochemical and cellular mechanisms of inflammatory response to silk fibroin, new cellular mechanisms leading to the failure of cardiovascular stents and the tissue regeneration potential of novel soybean-based biomaterials and biomimetic dendrimers.